TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Curl-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Push-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plank
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lateral bridge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30 seconds sit to stand test (30STS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in fasting inflammatory blood markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Units of red blood cells transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Supine AHI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Breastfeeding blues
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Effect on allergic rhinitis symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hemodynamic effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Computerized Dynamic Visual Acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Sensory Organization Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in retina edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients found to have a cCR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metastasis free survival at 2 years
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in pulmonary gas exchange
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Family Experiences Interview Schedule (FEIS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: percentage of correct speech recognition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants with at least One Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants with Specified AEs (Local Reactions) at the Vaccination Site
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants with Specified AEs (Systemic Events)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Patient Reported Outcomes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of the vascular Access Complications occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Functional disability measured through Foot Function Index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Best Corrected Low Luminance Visual Acuity (LLVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Retinal Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: New episode of shoulder dislocation or subluxation
Endpoint domain: Adverse events/effects
Primary endpoint: Achievement Percentage
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Urine osmotic excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Anaerobic threshold (AT) measured in ml/kg/min
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum oxygen consumption (VO2 peak) measured in ml/kg/min
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 9 Hole Peg Test (NHPT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with Modified Rankin Scale (mRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neck Pain Changing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eczema area and severity index (SA-EASI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life EQ-5D-5L French Index Score Change
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Walking Ability Change
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Hemodialysis Comfort Scale Version II
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: percentage of reduction in muscle mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Early graft dysfunction score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of score of the QoL questionnaire (PedsQL 4.0)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change of score of the QoL questionnaire (Short form-36)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of patients alive and progression-free from disease at 1 year
Endpoint domain: Mortality/survival
Primary endpoint: Successful weaning from sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with femoral approach surgical site infection (SSI)
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of HMPV infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Pain Medication Questionnaire (PMQ)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Opioid Risk Tool (ORT)
Endpoint domain: Adverse events/effects
Primary endpoint: Ear pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes in clinical performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pyruvate dehydrogenase activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified International Cooperative Ataxia Rating Scale (MICARS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Robertson dysarthria profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ratio of hemodialysis to non-hemodialysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Time to detection of microbiologically proven TB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Fluorescence assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Beans Clamping in 1 minute
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Neurogenic Pain after each session
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Muscle Spasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Self-perceived quality of life via WHO Brief QoL questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in neuropathic pain after the 4 weeks of the program
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in oxygen saturation (SpO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in cerebral oxygenation (C-rSO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in cerebral fractional oxygen extraction (c-FOE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: choice accuracy in learning task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: interoceptive accuracy in heartbeat counting task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Psychological well-being - improvement in coherence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Fecal Immunochemical Test (FIT) kit return rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Dim light Melatonin Onset Phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Number of Participants Who Received 1, 2, or 3 Doses of Treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants for Whom the First Attempt Failed to Insert the Catheter/Endotracheal Tube
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Maneuvers Discontinued Due to Neonate's Severe Destabilization
Endpoint domain: Adverse events/effects
Primary endpoint: Sensitivity for HCC detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Positivity of total anti-SARS-CoV-2 blood Ig
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Symptom Checklist 20 (SCL 20)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Success rate of measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of complications related to measurements
Endpoint domain: Adverse events/effects
Primary endpoint: Global perceived experience of the patient with the measurement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pain scale measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete Remission (CR) without MRD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients needing rescue analgesic
Endpoint domain: Adverse events/effects
Primary endpoint: rate of adequate bowel preparation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion of patients satisfying dry eye disease criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trunk Extensor Endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Trunk Flexor Endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Lateral Endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Pharmacokinetics of Levetiracetam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ophthalmic manifestations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in exacerbation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in blood eosinophil levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Insulin stimulated change in glucose disposal rate (low dose HEC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Insulin stimulated change in glucose disposal rate (high dose HEC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in liver proton density fat fraction (PDFF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in fat content in muscles of interest
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Liver Fibroinflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Perceived severity of patient stressors
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Erythema Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of participants who experience pain post-op
Endpoint domain: Adverse events/effects
Primary endpoint: Total amount of drainage from drain site
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rate of symptomatic VTE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Post bleaching sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of infectious and inflammatory disease
Endpoint domain: Adverse events/effects
Primary endpoint: Feasibility of CALM intervention as measured by rates of participant screening, eligibility, and consent
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Feasibility of CALM intervention as measured by attendance at CALM sessions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Feasibility of CALM intervention as measured by rates of post-session assessment completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Feasibility of CALM intervention as measured by follow-up assessment completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Benefit of intervention as measured by participant responses to exit interview questions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in urine protein to creatinine concentration ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Proportion of complete biochemical remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Any diagnosis of COVID-19
Endpoint domain: Mortality/survival
Primary endpoint: Hospital admission for COVID-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Intensive unit care because of a diagnosis of COVID-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: ddPCR sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of broad-spectrum antibiotic dispensing
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: 12-month Treatment Success Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of score of 0-3 on the modified Rankin scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: new silent brain infarctions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: accuracy of upper GI bleeding scoring systems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: prognostic value of upper GI bleeding scoring systems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative self-judgment frequency during task
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Default mode network activation during task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Characterization of uterine fibroids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention of subjects in study assessments
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time required to enroll subjects into study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in BOLD response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serve Velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of concordant scans
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RAPS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PBMC proliferation, differentiation or activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Onset of acute graft-versus-host disease (aGvHD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of participants enrolled to the study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of participants that complete the study
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change of direction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of reaction time z scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Myocardial inflammation detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Desire to Smoke
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Efficacy of CBL-514
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of segmental Le Fort I bone movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Stability of segmental Le Fort I bone movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Stability of the upper airway
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Major Cardiovascular and Cerebrovascular Events (MACCE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Abstinence from tobacco use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of mechanical failure
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in B cell populations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: concentration of pro-inflammatory cytokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: concentration of markers of oxidative stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: concentration of NfL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: concentration of GFAP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: concentration of ecDNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with readmission for heart failure
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Urine cannabinoids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Bilirubin-Total
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Serum aspartate aminotransferase (AST/SGOT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Serum alanine transaminase (ALT/SGPT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Presence of pulmonary nodules
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Sensitivity of caries diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of caries diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of caries diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of infected children
Endpoint domain: Adverse events/effects
Primary endpoint: Distribution of diabetic retinopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Pain assessed by visual analog pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comparison of preferred roles vs actual roles in decision-making
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Partial pressure of carbon dioxide in peripheral blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immune response to mRNA-1273.214
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Sensory Integration and Praxis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper limb muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Trunk flexor isometric strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Abdominopelvic muscle function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Knee pain measured through the oxford pain score questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Patient Health Questionnaire-15 score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Brief Pain Inventory -4 score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: oxygen uptake (VO2) during peak exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of 6-month PFS
Endpoint domain: Mortality/survival
Primary endpoint: Numerical values of CPET-derived variables
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patency of no-touch saphenous vein graft
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Percentage of patients with adequate Osteoporotic treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive functioning as measured by the Tower of London test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Carbon dioxide levels during preterm resuscitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of distal radial artery occlusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes